Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / CL A
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
11,193,182
-
Shares change
-
+372,419
-
Total reported value, excl. options
-
$316,693,904
-
Value change
-
+$7,878,399
-
Put/Call ratio
-
0%
-
Number of buys
-
48
-
Number of sells
-
-29
-
Price
-
$28.32
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2017
100 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q4 2017.
REATA PHARMACEUTICALS INC - CL A (RETA) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,193,182 shares
.
Largest 10 shareholders include CPMG Inc (2,912,523 shares), BlackRock Inc. (1,203,993 shares), FMR LLC (659,291 shares), Vanguard Group Inc (612,642 shares), EMERALD ADVISERS INC/PA (561,736 shares), Laurion Capital Management LP (518,091 shares), EMERALD MUTUAL FUND ADVISERS TRUST (459,184 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (390,000 shares), FRANKLIN RESOURCES INC (265,434 shares), and PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (250,000 shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.